Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older by the FDA after an extensive review of safety and efficacy data.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly updates. But vaccine experts are mystified by its focus on a dated technology.

The newly released Global Swine Vaccine Market analysis report by Future Market Insights reveals that the global market for ...

What the shingles vaccine does is it dampens reactivations of latent viruses in a way that may be protecting other parts of your body,” Martin said. Including, it seems, the brain. The measles, mumps ...